Impact of Increased Body Mass Index on Adolescent Fixed Orthodontic Treatment. A Prospective Longitudinal Study
NCT ID: NCT07217756
Last Updated: 2025-10-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
52 participants
OBSERVATIONAL
2022-04-22
2026-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Do patients with an increased BMI undergoing OT demonstrate increased microbial counts in the saliva compared to patients with normal BMI?
2. Do patients with increased BMI undergoing OT demonstrate increased gum inflammation, tooth discolorations, and higher levels of inflammatory markers in the saliva and gum fluid samples compared to patients with normal BMI? This study will include 2 study groups (patients with increased BMI-test group, and normal weight patients-control group). The participants will be asked to complete a study questionnaire, which will collect information regarding their demographics, their family socioeconomic and educational status, dietary habits, and oral health-related quality of life. The participants will also receive an oral examination (evaluation of their gum health), and they will have their intraoral photos taken, as well as an impression of their lower teeth (to create dental models). A saliva sample will be obtained by asking patients to passively "drool" in a tube, and a gingival fluid sample will be collected from the gums of the lower anterior teeth using thin paper strips. All these study procedures will be conducted at baseline (T1: before bonding of braces), and at an approximately 6-month follow-up visit (T2). Comparisons of these outcomes will be conducted between the two groups and across timepoints.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Orthodontic Treatment on Oral Microbiota and Salivary Proteins
NCT06824493
The Prevalence of White Spot Lesions During Orthodontic Treatment With Fixed Appliances
NCT04186065
Changes in Streptococcus Mutans Colonization With Different Oral Hygiene Protocols in Adult Patients With Fixed Orthodontic Appliance
NCT05016713
Comparison of the Effectiveness of Three Teaching Methods in Oral Hygiene in Adolescent Orthodontic Patients
NCT04444154
Motivational Interviewing to Improve Oral Hygiene in Adolescent Orthodontic Patients
NCT07164989
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Increased BMI group (test group)
The increased BMI group will include patients with a BMI\>25.0 Kg/m2.
No interventions assigned to this group
Normal BMI group (control groups)
The normal-BMI group will include patients with a BMI between 18.5 and 24.99 (Kg/m2).
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients scheduled to undergo comprehensive fixed orthodontic therapy (OT) (for at least 6 months with metal braces/wires) on both dental arches;
* patients with increased BMI (≥25.0 Kg/m2) (test-Group);
* patients with normal BMI \[18.5-24.99 (Kg/m2)\] (control-Group);
* patients with all 6 mandibular anterior teeth present and mild-to-moderate mandibular crowding (\<7.5 mm);
* patients and parents/guardians willing to provide signed assent/permission.
Exclusion Criteria
* patients with self-reported medical diseases such as hepatic diseases, blood disorders, cardiovascular diseases, HIV, diabetes mellitus, and viral infections;
* patients with craniofacial syndromes and/or cleft lip and palate;
* pregnant and/or lactating females (by self/parent report);
* edentulous individuals;
* patients with active or a history of periodontitis;
* patients having undergone surgical and/or non-surgical periodontal therapy within the past 6 months;
* patients with physical and/or mental/cognitive disabilities who are decisionally-impaired and not able to consent/assent for themselves;
* patients who reported use of medications such as antibiotics, steroids (inhalers and/or pills), non-steroidal anti-inflammatory drugs, and antimicrobial mouth-rinses within the past 3 months or those who require prophylactic antibiotics prior to dental procedures;
* patients undergoing cancer therapy;
* underweight patients (BMI less than 18.5 Kg/m2);
* patients with oral mucosal lesions such as median rhomboid glossitis and lichen planus;
* patients with clinically visible carious teeth.
12 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Association of Orthodontists Foundation
UNKNOWN
University of Rochester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dimitrios Michelogiannakis
Associate Professor, Program Director of the Orthodontics Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dimitrios Michelogiannakis, DDS, MS
Role: PRINCIPAL_INVESTIGATOR
Eastman Institute for Oral Health, University of Rochester
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eastman Institute for Oral Health, University of Rochester
Rochester, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00005905
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.